Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Mirum Pharmaceuticals, Inc. (MIRM) had Income from Continuous Operations of $2.90M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$133.01M |
|
$2.90M |
|
$25.54M |
|
$107.47M |
|
$130.41M |
|
$2.60M |
|
$0.04M |
|
$2.64M |
|
$2.64M |
|
$2.90M |
|
|
Income from Continuous Operations |
$2.90M |
$2.90M |
|
$2.90M |
|
$2.60M |
|
$9.11M |
|
50.64M |
|
56.99M |
|
$0.06 |
|
$0.05 |
|
| Balance Sheet Financials | |
$530.58M |
|
$1.28M |
|
$254.54M |
|
$785.12M |
|
$160.36M |
|
$309.37M |
|
$332.71M |
|
$493.07M |
|
$292.05M |
|
$60.15M |
|
$292.05M |
|
51.31M |
|
| Cash Flow Statement Financials | |
$49.76M |
|
$-24.96M |
|
$31.14M |
|
$222.93M |
|
$282.50M |
|
$59.57M |
|
$52.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.31 |
|
-- |
|
-- |
|
0.51 |
|
1.06 |
|
80.80% |
|
1.96% |
|
1.96% |
|
-- |
|
1.99% |
|
2.18% |
|
$49.41M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
1.06 |
|
1.24 |
|
72.49 |
|
0.99% |
|
4.83% |
|
0.37% |
|
0.48% |
|
$5.69 |
|
$0.87 |
|
$0.87 |
|